Kala Pharmaceuticals Inc. (KALA)

NASDAQ: KALA · Real-Time Price · USD

3.74

-0.23 (-5.79%)

At close: May 01, 2025, 3:58 PM

3.70

-1.07%

After-hours: May 01, 2025, 07:33 PM EDT

Kala Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	3.89M	11.24M	6.36M	6.07M	n/a	n/a	n/a
Cost of Revenue	n/a	303K	2.56M	4.1M	3.17M	2.01M	955K	643K	297K
Gross Profit	n/a	-303K	1.33M	7.14M	3.19M	4.07M	-955K	-643K	-297K
Operating Income	-40.98M	-39.15M	-81.36M	-109.43M	-96.23M	-88.22M	-64.72M	-39.88M	-32.67M
Interest Income	2.06M	2.71M	664K	104K	493K	2.36M	1.69M	527K	147K
Pretax Income	-38.51M	-42.2M	-44.82M	-142.6M	-104.33M	-94.35M	-66.74M	-42.21M	-33.17M
Net Income	-38.51M	-42.2M	-223K	-152.3M	-112M	-101.98M	-66.74M	-42.21M	-33.17M
Selling & General & Admin	18.34M	20.26M	65.03M	105.06M	81.07M	65.02M	35.43M	10.87M	7.64M
Research & Development	22.09M	18.59M	17.65M	11.52M	18.35M	27.27M	29.29M	29.01M	25.03M
Other Expenses	n/a	n/a	-926K	1.31M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	40.43M	38.85M	82.69M	116.58M	99.42M	92.29M	64.72M	39.88M	32.67M
Interest Expense	-5.78M	5.81M	7.27M	8.38M	8.59M	8.48M	3.31M	1.02M	767K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	40.98M	39.15M	85.25M	120.67M	102.59M	94.3M	64.72M	39.88M	32.67M
Income Tax Expense	n/a	n/a	-44.6M	9.69M	7.68M	7.64M	1.3M	732K	767K
Shares Outstanding (Basic)	37.96M	2.43M	1.52M	1.3M	1.05M	684.2K	535.08K	138.06K	345.67K
Shares Outstanding (Diluted)	37.96M	2.43M	1.52M	1.3M	1.05M	684.2K	535.08K	138.06K	345.67K
EPS (Basic)	-1.01	-17.35	-0.15	-116.79	-106.92	-149.06	-124.73	-305.74	-95.95
EPS (Diluted)	-1.01	-17.35	-0.15	-116.79	-106.92	-149.06	-124.73	-305.74	-95.95
EBITDA	-40.98M	-36.08M	-36.7M	-131.96M	-92.9M	-83.25M	-62.47M	-40.55M	-32.1M
EBIT	-44.29M	-36.38M	-37.56M	-134.22M	-95.74M	-85.87M	-63.42M	-41.19M	-32.4M
Depreciation & Amortization	3.31M	303K	860K	2.27M	2.84M	2.62M	955K	643K	297K